Identification of Dutch children diagnosed with atopic diseases using prescription data: a validation study

B Mulder1, F Groenhof2, L I Kocabas3

  • 1Department of PharmacoEpidemiology and PharmacoEconomics University Centre of Pharmacy, University of Groningen, P.O. Box XB45, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands. b.mulder@rug.nl.

Insights

Medication proxies reliably identify children with asthma using prescription data. However, using these proxies for identifying children with atopic dermatitis or allergic rhinitis is questionable due to low sensitivity.

Area of Science:

  • Pediatric Epidemiology
  • Pharmacological Research
  • Public Health

Background:

  • Atopic disorders, including asthma, atopic dermatitis, and allergic rhinitis, are common in children.
  • Accurate identification of these conditions is crucial for epidemiological research and healthcare planning.
  • Medication prescription data offers a potential resource for identifying affected children in large populations.

Purpose of the Study:

  • To validate medication prescription data as proxies for identifying children diagnosed with atopic disorders.
  • To assess the reliability of these proxies across different atopic conditions and age groups.
  • To determine optimal criteria for using medication proxies in epidemiological studies.

Main Methods:

  • Utilized a general practitioner database (Registration Network Groningen) in the Netherlands.
  • Analyzed records of 7439 children aged 0-10 years from 2001-2010.
  • Calculated sensitivity and positive predictive value (PPV) for 22 medication proxies against registered diagnoses, testing various prescription capture periods.

Main Results:

  • A proxy of ≥2 anti-asthma prescriptions within 1 year, including an inhaled steroid, showed high PPV (0.84) and sufficient sensitivity (0.54) for asthma identification.
  • These asthma proxies performed better in older children (6-10 years).
  • Proxies for atopic dermatitis and allergic rhinitis had high PPVs but low sensitivity, questioning their utility.

Conclusions:

  • Medication prescription data can reliably identify children diagnosed with asthma.
  • The use of prescription data as proxies for identifying children with atopic dermatitis and allergic rhinitis is questionable due to poor sensitivity.
  • Further research may be needed to refine proxies for non-asthma atopic conditions.
Abstract